Back to Search
Ogen 1.25
by Pfizer IncMHTTablet (Oral)
DiscontinuedReference Drug

Estrogen

Non-Bioidentical

Estropipate

1.25Mg

Estrogen Dose Type

Medium

Approval Date

1/1/1982

Inactive Ingredients
LactoseHydrogenated vegetable oil waxColloidal silicon dioxideDibasic potassium phosphateHydroxypropyl celluloseMagnesium stearateMicrocrystalline celluloseSodium starch glycolateTromethamineFD&C Yellow No. 6

Contains common allergens

Alternative Doses Available
This drug is available in different dose strengths. Currently viewing: Medium dose

Ultra High Estrogen Dose

Ogen 5Estropipate 6Mg

Unspecified Progesterone Dose

Estropipate 6Mg

No active alternative brands with the same formulation

Have clinical questions about Ogen 1.25?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy